# Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles

> **NCT01816789** · PHASE4 · TERMINATED · sponsor: **Andros Day Surgery Clinic** · enrollment: 194 (actual)

## Conditions studied

- In Vitro Fertilization
- Ovarian Stimulation

## Interventions

- **DRUG:** rFSH
- **DRUG:** buserelin

## Key facts

- **NCT ID:** NCT01816789
- **Lead sponsor:** Andros Day Surgery Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 194 (ACTUAL)
- **Why stopped:** Optimal response: 63% nomogram, 42% controls, overcoming the stopping rule for interim analysis
- **Last updated:** 2016-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01816789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01816789, "Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01816789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*